- AttorneyOne.com – Finding An Attorney Online, Just Got Easier

The FDA informs Pharmacists, Patients and healthcare professionals that Carboplatin Injection is recalled due to visible particulates identified as Carboplatin crystals that may cause vasculitis, local infarction and thromboembolism. Background of Carboplatin Injection Carboplatin Injection, by Hospira Inc., is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic [...]

The US FDA notifies Oncology and Surgery healthcare professionals that Ondansetron (Zofran) 32 mg will stop being marketed because of the potential for serious cardiac risks. Background of Ondansetron (Zofran) Zofran (Ondansetron), by GlaxoSmithKline, is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic (to treat nausea and vomiting), often following chemotherapy. FDA Alert [...]

The US FDA informed Oncology and Hematology Healthcare Professionals that Mylotarg (gemtuzumab ozogamicin) is not commercially available to new patients. New concerns were raised about the drug’s safety. Background of Mylotarg Mylotarg (gemtuzumab ozogamicin), by Pfizer Inc., was used for the treatment of acute myeloid leukemia (AML), a bone marrow cancer. The drug was approved [...]

Oncology and Cardiology healthcare personnel are informed by the FDA that the injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting related to cancer chemotherapy because the risk of developing abnormal heart rhythm exists. Background of Anzemet Cardiovascular safety concerns have already been noted by the FDA suggesting [...]